Apixaban/aspirin/warfarinVarious toxicities, off-label use and lack of efficacy: 6 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1915卷 / 1期

关键词：

D O I：

10.1007/s40278-022-19098-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：69 / 69

相关论文

共 50 条

[21] Adalimumab/methotrexateVarious toxicities, lack of efficacy and off-label use: 8 case reports
[J]. Reactions Weekly, 2023, 1965 (1) : 23 - 23
[22] Dexamethasone/methylprednisoloneVarious toxicities, lack of efficacy and off-label use: 3 case reports
[J]. Reactions Weekly, 2023, 1968 (1) : 119 - 119
[23] BosutinibVarious toxicities and lack of efficacy following off-label use: 5 case reports
[J]. Reactions Weekly, 2022, 1918 (1) : 111 - 111
[24] Multiple drugsVarious toxicities, lack of efficacy and off-label use: 5 case reports
[J]. Reactions Weekly, 2023, 1985 (1) : 376 - 376
[25] Multiple drugsVarious toxicities, lack of efficacy and off-label use: 8 case reports
[J]. Reactions Weekly, 2023, 1984 (1) : 383 - 383
[26] Multiple drugsVarious toxicities, off-label use and lack of efficacy: 2 case reports
[J]. Reactions Weekly, 2021, 1875 (1) : 253 - 253
[27] Multiple drugsVarious toxicities, lack of efficacy and off-label use: 5 case reports
[J]. Reactions Weekly, 2023, 1943 (1) : 528 - 528
[28] Apixaban/rivaroxaban overdoseVarious toxicities and off-label use: 2 case reports
[J]. Reactions Weekly, 2022, 1897 (1) : 68 - 68
[29] TopiramateVarious toxicities and off-label use: 6 case reports
[J]. Reactions Weekly, 2022, 1933 (1) : 399 - 399
[30] Ambrisentan/bosentanVarious toxicities following off-label use and lack of efficacy: 8 case reports
[J]. Reactions Weekly, 2021, 1886 (1) : 34 - 34

← 1 2 3 4 5 →